Abd-Elaziz, Khalid https://orcid.org/0000-0002-0964-4940
Voors-Pette, Christine
Wang, Kang-Ling
Pan, Sandy
Lee, Yisheng
Mao, John
Li, Yuhua
Chien, Benjamin
Lau, David
Diamant, Zuzana
Funding for this research was provided by:
Foresee Pharmaceuticals Co., Ltd. Taipei, Taiwan
Article History
Accepted: 21 October 2020
First Online: 17 December 2020
Declarations
:
: Both studies were funded by Foresee Pharmaceuticals Co., Ltd. Taipei, Taiwan.
: K.A-E., C.V-P., B.C. to employee of Foresee, and Z.D. are employees of QPS-Netherlands, B.V., a CRO that received funding for the studies from Foresee Pharmaceuticals Co., Ltd. D.L, Y.L., Y.L., and J.M. are employees of Foresee Pharmaceuticals Co., Ltd. In the past 3 years, ZD also received consultancy honoraria from Aquilon, ALK, Acucort, Astrazeneca, Boehringer Ingelheim, CSL, HAL Allergy, MSD, and Sanofi-Genzyme. K.L.W has received honoraria from Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Novartis, Orient EuroPharm, and Pfizer.
: Study I was approved by the Institutional Review Board, Taipei Veterans General Hospital, Taipei, Tawian. Study II was approved by the Independent Ethics Committee, Stichting BeBo, Assen, the Netherlands.
: All subjects provided written informed consent prior to study enrollment.
: Not applicable.
: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
: Not applicable.
: All the authors contributed to the conception and design, collection and assembly of data, data analysis and interpretation, and manuscript writing, and provided final approval of the manuscript.
Free to read: This content has been made available to all.